How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs

This study has been completed.
Sponsor:
Information provided by:
Technische Universität München
ClinicalTrials.gov Identifier:
NCT00514423
First received: August 9, 2007
Last updated: August 28, 2014
Last verified: August 2014
  Purpose

Participation in one of the three interventions psychoeducation by professionals, psychoeducation by peer-moderators, or video-education can reduce the rehospitalisation rate of patients with schizophrenia compared to a control group.


Condition Intervention
Schizophrenia
Schizoaffective Disorder
Other: Psychoeducation by professonals
Other: Psychoeducation by peer-moderators
Other: Video-education
Other: Noneducational video group (control group)

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs

Resource links provided by NLM:


Further study details as provided by Technische Universität München:

Primary Outcome Measures:
  • Rehospitalisation rate

Secondary Outcome Measures:
  • Rehospitalisation days
  • Resulting costs per patient
  • Compliance
  • Knowledge of illness
  • Attitude towards illness
  • Quality of life
  • Satisfaction with treatment
  • Duration of consultation time
  • Dealing with mental illness

Estimated Enrollment: 896
Study Start Date: September 2006
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 2
Psychoeducation by peer-moderators
Other: Psychoeducation by peer-moderators
Experimental: 1
Psychoeducation by professionals
Other: Psychoeducation by professonals
Experimental: 3
Video-education
Other: Video-education
Placebo Comparator: 4
Control group
Other: Noneducational video group (control group)

  Eligibility

Ages Eligible for Study:   18 Years to 67 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Schizophrenia or schizoaffective disorder (ICD-10)
  • Age 18 to 67 years
  • Hospitalised or treated in day care clinic

Exclusion Criteria:

  • More than 12 months of hospitalisation within the last two years
  • Substance-dependency (principal diagnosis)
  • Mental retardation ICD-10 Chapter F70-79
  • Fluency of German language not given
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00514423

Locations
Germany
Klinik und Poliklinik für Psychiatrie und Psychotherapie am Klinikum rechts der Isar der Technischen Universität München
München, Germany, 81675
Sponsors and Collaborators
Technische Universität München
Investigators
Principal Investigator: Werner Kissling, MD Technische Universität München
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00514423     History of Changes
Other Study ID Numbers: 01GL0509, ISRCTN19638644
Study First Received: August 9, 2007
Last Updated: August 28, 2014
Health Authority: Germany: Federal Ministry of Education and Research

Additional relevant MeSH terms:
Schizophrenia
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on October 02, 2014